Everpar Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$258K Buy
+667
New +$247K 0.07% 248
2026
Q1
Sell
-881
Closed -$309K 289
2025
Q4
$309K Buy
881
+92
+12% +$31.1K 0.11% 194
2025
Q3
$255K Buy
+789
New +$245K 0.1% 230
2025
Q2
Sell
-608
Closed -$264K 271
2025
Q1
$264K Buy
+608
New +$244K 0.14% 205

Other funds holding ELV

Everpar Advisors's ELV Position: Q2 2026 in Review

Everpar Advisors opened a new position in Elevance Health (ELV) in Q2 2026: 667 shares worth $258K. The stake represents 0.07% of the portfolio and ranks #248 among its holdings. This is a return to the name: Everpar Advisors previously reported a position in ELV as recently as Q4 2025.

Everpar Advisors first reported a position in ELV in Q1 2025 and has held it in 4 quarters since. The position peaked at $309K in Q4 2025. 222 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Everpar Advisors held 667 shares of Elevance Health worth $258K as of Q2 2026.
  • Elevance Health was a new Everpar Advisors position in Q2 2026.
  • Elevance Health made up 0.07% of Everpar Advisors's portfolio in Q2 2026, its #248 holding.
  • Everpar Advisors first reported a position in Elevance Health in Q1 2025 and has held it in 4 quarters since.
  • Everpar Advisors's Elevance Health position peaked at $309K in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Everpar Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.